ARPE-19—A Stable Cell Line Expressing a Variant of Unknown Significance in the NPC1 Gene
Authors:
- Beatriz MonteiroBeatriz Monteiro
- Maria Inês PeixotoMaria Inês Peixoto
- Juan Darío Ortigoza-EscobarJuan Darío Ortigoza-Escobar
- Mariana AlvesMariana Alves
- Ana Catarina SandiaresAna Catarina Sandiares
- Mariana GonçalvesMariana Gonçalves
- Luciana Vaz MoreiraLuciana Vaz Moreira
- Maria Francisca CoutinhoMaria Francisca Coutinho
- Liliana MatosLiliana Matos
- Sandra AlvesSandra Alves
- Marisa EncarnaçãoMarisa Encarnação
Open Access
Abstract
Background: Niemann–Pick type C is a lysosomal storage disorder that results from pathogenic variants in the NPC1 gene or in some cases from NPC2 pathogenic alterations. The disease presents a remarkable clinical variability that in some cases resembles common diseases, often resulting in a diagnostic odyssey or at least delaying proper diagnosis. In addition, the NPC1 gene is highly polymorphic, and consequently, when missense variants are identified after gene sequencing, accurate classification of their pathogenicity is essential to ensure appropriate access to available therapies and to provide reliable genetic counseling. Objectives: To get insights into the pathogenicity of a novel variant in NPC1, p.Cys800Ser, we created stable cell lines expressing this variant, in parallel with cell lines expressing the NPC1 wild-type and NPC1 pathogenic variants. Methods: We leveraged an isogenic cell line in which the NPC1 gene was knocked down and subsequently infected it with retroviruses carrying NPC1-WT and NPC1 variants C-terminally fused with an mNeonGreen tag. Three different NPC1 variants were included in this study: two known pathogenic variants, p.Ala1035Val and p.Pro1007Ala, and the novel p.Cys800Ser, whose significance was unknown. Results: We observed in the stable cell line expressing NPC1 p.Cys800Ser that the mutated NPC1 protein is transported to the lysosome similarly to the p.Pro1007Ala variant and affects lysosomal distribution. Conclusions: Using this approach, we could analyze the pathogenicity of each variant separately and these cell lines could be used for personalized medicine-based approaches and multi-omic studies.Keywords
Funding Information
- Portuguese Foundation for Science and Technology (UIDB/00211/2020)
- Portuguese Foundation for Science and Technology (LA/P/0059/2020)
This publication has 19 references indexed in Scilit:
- At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 yearsEuropean Journal of Human Genetics, 2023
- Saturation variant interpretation using CRISPR prime editingNature Biotechnology, 2022
- NPC1 silent variant induces skipping of exon 11 (p.V562V) and unfolded protein response was found in a specific Niemann‐Pick type C patientMolecular Genetics & Genomic Medicine, 2020
- Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical reviewMolecular Genetics and Metabolism, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C diseaseJournal of Neurology, 2013
- Niemann-Pick Type C1 I1061T Mutant Encodes a Functional Protein That Is Selected for Endoplasmic Reticulum-associated Degradation Due to Protein MisfoldingJournal of Biological Chemistry, 2008
- Identification of 58 novel mutations in Niemann-Pick disease type C: Correlation with biochemical phenotype and importance ofPTC1-like domains inNPC1Human Mutation, 2003
- Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterationsHuman Genetics, 2001
- Dynamic Movements of Organelles Containing Niemann-Pick C1 Protein: NPC1 Involvement in Late Endocytic EventsMolecular Biology of the Cell, 2001